Serological tumor markers, including Carbohydrate Antigen 199 (CA19-9), CA-125, and CEA, are crucial in the preoperative assessment of mucinous ovarian tumors and provide valuable insights during the evaluation of frozen sections. This evidence concerns the gene CEACAM5 and neoplasm.